Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Germany
|
| gptkbp:focusesOn |
neurology
movement disorders neurotoxins |
| gptkbp:foundedBy |
gptkb:Friedrich_Merz
|
| gptkbp:foundedYear |
1908
|
| gptkbp:headquartersLocation |
gptkb:Frankfurt_am_Main
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:parentCompany |
Merz Group
|
| gptkbp:product |
gptkb:Radiesse
gptkb:Xeomin |
| gptkbp:website |
https://www.merztherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Merz_Pharma
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Merz Therapeutics
|